A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ANEMIA IN A SUITABLE CONTAINER, WHICH KEEPS THE ACTIVE INGREDIENTS SEPARATE IN A SEALED MANNER: THE IRON COMPLEX WITH N-ACETYL-L-ASPARTIC CASEIN AND CALCIUM FOLIATE PENTAHYDRATE
CY1126155T1Undetermined Publication Date: 2026-07-31TSETI IOULIA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100308T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-04-05
- Filing Date
- 2023-06-30
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-06-30
Abstract
The present invention relates to a pharmaceutical composition in the form of a single-dose oral solution comprising the iron complex with N-acetyl-L-aspartate casein and calcium folinate pentahydrate as active ingredients. The iron complex with N-acetyl-L-aspartate casein is formulated with ferric iron and complexed N-acetyl-L-aspartic acid and is stored in a cylindrical container in liquid form. The calcium folinate pentahydrate is stored in solid form in the closed storage cap and is kept separately in a sealed manner from the solution which is stored in the container. The container-closed storage cap device allows the mixing of the two active ingredients just before their administration as a single-dose oral solution. The obtained pharmaceutical composition helps to treat both chronic anemia and anemia during pregnancy and lactation.
Need to check novelty before this filing date? Find Prior Art